| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.28 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |